← Evidence map

Observational studyJapanese journal of clinical oncology2020

Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance study.

Shigeru Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2020
2021
2022
2023
2024
2025
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 32458996